Isabelle Mahé

Featured in: Favicon

springer.com Favicon

biomedcentral.com Favicon

onlinelibrary.wiley.com Favicon

jmedicalcasereports.biomedcentral.com

Articles

Low-dose apixaban for extended anticoagulation may be option for preventing cancer-related VTE

3 weeks ago | healio.com | Scott Buzby |Richard Smith |Geoffrey D. Barnes |Isabelle Mahé

Low-dose apixaban for extended anticoagulation may be option for preventing cancer-related VTE• Continued anticoagulation is recommended for patients with active cancer and/or ongoing cancer treatment. • Extended treatment with low-dose apixaban was noninferior to a full dose for preventing cancer-related VTE.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →